SEQUENT RESEARCH PRIVATE LIMITED

SEQUENT RESEARCH PRIVATE LIMITED is neither a factory nor a trader. It is a market research and data collection service provider.

Company Profile:

Location: India

Business Type: Market Research and Data Collection Service Provider

Description:

SEQUENT RESEARCH PRIVATE LIMITED is a well-established full-service market research agency based in India. The company specializes in offering comprehensive research solutions and actionable insights to businesses across a wide array of industries. Their core business involves collecting, processing, and analyzing data to help clients understand market dynamics, consumer behavior, product performance, and competitive environments.

Services Offered:

The services provided by SEQUENT RESEARCH PRIVATE LIMITED typically encompass a range of market research activities. These include:

Quantitative Research: Conducting large-scale surveys, polls, and statistical analysis.

Qualitative Research: Facilitating focus group discussions, in-depth interviews, and ethnographic studies.

Fieldwork Services: Managing data collection across various geographies in India.

Data Processing and Analysis: Transforming raw data into meaningful insights using advanced analytical tools.

Reporting and Consulting: Delivering strategic reports and recommendations based on research findings.

The company leverages various methodologies and technologies to ensure the accuracy and reliability of the data they collect, supporting their clients in making informed business decisions. They serve diverse sectors such as consumer goods, healthcare, automotive, finance, and technology.

API products: Abacavir, Atazanavir, Azacitidine, Bictegravir, Capecitabine, Decitabine, Doravirine, Emtricitabine, Enzalutamide, Erlotinib, Fludarabine, Gefitinib, Ibrutinib, Ledipasvir, Lenvatinib, Mercaptopurine, Niraparib, Osimertinib, Pemetrexed, Raltegravir, Regorafenib, Rilpivirine, Sofosbuvir, Sorafenib, Sunitinib, Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate, Tipiracil, Trametinib, Vemurafenib.

Formulation products: Sofosbuvir/Velpatasvir, Sofosbuvir/Ledipasvir, Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate, Doravirine/Tenofovir Disoproxil Fumarate/Lamivudine, Bictegravir/Emtricitabine/Tenofovir Alafenamide.